Mustang Bio Current Valuation vs. Debt To Equity
| MBIO Stock | USD 0.20 0.01 5.26% |
For Mustang Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Mustang Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Mustang Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Mustang Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Mustang Bio over time as well as its relative position and ranking within its peers.
Mustang |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.33) | Revenue Per Share (0) | Return On Assets (0.97) | Return On Equity (11.91) |
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Mustang Bio Debt To Equity vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Mustang Bio's current stock value. Our valuation model uses many indicators to compare Mustang Bio value to that of its competitors to determine the firm's financial worth. Mustang Bio is rated below average in current valuation category among its peers. It is regarded second in debt to equity category among its peers . The ratio of Current Valuation to Debt To Equity for Mustang Bio is about 18,516,278 . At this time, Mustang Bio's Debt To Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mustang Bio's earnings, one of the primary drivers of an investment's value.Mustang Current Valuation vs. Competition
Mustang Bio is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 1.26 Billion. Mustang Bio maintains roughly 6.54 Million in current valuation contributing less than 1% to equities under Health Care industry.
Mustang Debt To Equity vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Mustang Bio |
| = | 6.54 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Mustang Bio |
| = | 0.35 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Mustang Debt To Equity Comparison
Mustang Bio is currently under evaluation in debt to equity category among its peers.
Mustang Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Mustang Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Mustang Bio will eventually generate negative long term returns. The profitability progress is the general direction of Mustang Bio's change in net profit over the period of time. It can combine multiple indicators of Mustang Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 591 K | 561.5 K | |
| Operating Income | -50.7 M | -53.3 M | |
| Net Loss | -62.6 M | -65.8 M | |
| Income Before Tax | -51.6 M | -54.2 M | |
| Total Other Income Expense Net | -876 K | -832.2 K | |
| Net Loss | -69.8 M | -66.3 M | |
| Net Loss | -51.6 M | -54.2 M | |
| Income Tax Expense | 1.2 M | 1.2 M | |
| Net Interest Income | -4.2 M | -4 M | |
| Interest Income | 1.1 M | 710.6 K | |
| Non Operating Income Net Other | 814.2 K | 638.4 K | |
| Change To Netincome | 12.7 M | 9.7 M | |
| Net Loss | (6.00) | (6.30) | |
| Income Quality | 0.96 | 0.50 | |
| Net Income Per E B T | 1.17 | 1.11 |
Mustang Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Mustang Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Mustang Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Mustang Bio's important profitability drivers and their relationship over time.
Use Mustang Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Mustang Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mustang Bio will appreciate offsetting losses from the drop in the long position's value.Mustang Bio Pair Trading
Mustang Bio Pair Trading Analysis
The ability to find closely correlated positions to Mustang Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Mustang Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Mustang Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Mustang Bio to buy it.
The correlation of Mustang Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Mustang Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Mustang Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Mustang Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Mustang Bio position
In addition to having Mustang Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
To fully project Mustang Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Mustang Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Mustang Bio's income statement, its balance sheet, and the statement of cash flows.